Alizee J. Grimm
Lausanne Branch
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach.
Journal: Nature reviews. Clinical oncology
Published: August 12, 2024
Crosstalk of T cells within the ovarian cancer microenvironment.
Journal: Trends in cancer
Published: June 28, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Journal: Science immunology
Published: February 02, 2024
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.
Journal: Nature
Published: May 22, 2023
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells.
Journal: Nature
Published: May 22, 2023
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.
Journal: Journal for immunotherapy of cancer
Published: June 29, 2020
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.
Journal: Cell reports
Published: May 28, 2020
Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
Journal: Current opinion in biotechnology
Published: December 30, 2019
Last Updated: 09/26/2026